Marksans Pharma recalls one batch of Metformin Extended Release Tablets

08 Jun 2020 Evaluate
Marksans Pharma has issued voluntary recall of one batch of Metformin Extended Release Tablets USP 500 mg (11279 bottles, Lot No. XP9004) due to detection of NDMA as a matter of abundant precaution.

Metformin Extended Release Tablets USP 500 mg is indicated as an adjunct to diet and exercise to improve blood glucose control in adults with type 2 diabetes mellitus.

Marksans Pharma together with its subsidiaries operates as an integrated international pharmaceutical company. The company’s business is distribution of pharmaceutical products.

Marksans Pharma Share Price

183.95 -3.95 (-2.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×